A peptide product catalog packs a surprising amount of structured information into a short product title and a handful of variant labels. Once you know the convention, a listing tells you the compound, the package size, and — for combination products — exactly which components make up the blend, all without opening the CoA. This is a reference for reading that structure, not a guide to choosing between compounds.
Compound codes and sequence identifiers
Most single-peptide listings pair a common name (the name most researchers search for) with a compound code — a short internal identifier a catalog uses to key SKUs, inventory records, and CoAs to the same compound consistently, independent of which display name a listing uses at a given time. The common name is what shows up in the title; the compound code is what ties every size variant, every lot, and every CoA of that compound together on the backend. When a product page or CoA mentions a sequence identifier or CAS number, that’s a further, unambiguous layer: unlike a common name — which can vary across suppliers or even shift over time for the same compound — a sequence or CAS number identifies one specific molecule with no room for naming drift.
Reading a blend name
A blend product’s name is typically constructed directly from its components: a listing named after a combination of two compounds is telling you, in the name itself, exactly which two single peptides make up the vial and in most cases their approximate ratio or relative proportion. This differs structurally from a single- peptide listing in one important way for documentation purposes: a blend’s CoA needs to account for each component separately (or for the combined preparation as its own tested entity), since a purity or identity result run against one component alone doesn’t characterize the blend as a whole. Reading a blend listing means checking whether the CoA on file tests the blend itself or only its individual inputs — the two are different documentation claims.
Package-size conventions
Package size is usually encoded two ways on a catalog listing: the per-vial fill amount (stated in milligrams, e.g. 5 mg, 10 mg) and a pack-quantity suffix describing how many vials ship as a unit (a single vial versus a multi-vial pack). The two are independent variables — a catalog commonly offers the same compound at several milligram strengths, each of which can then be ordered as a single vial or as a multi-vial pack — so a size selector on a product page is usually choosing both dimensions at once. A starter or bundled kit listing typically packages several distinct SKUs together as one purchasable unit (for instance, a peptide vial alongside a compatible accessory item); reading the kit’s contents list is the only reliable way to confirm exactly what SKUs and quantities are included, since the kit-level title alone doesn’t enumerate them.
SKUs, variants, and category structure
Beneath the display name, a catalog typically assigns each sellable combination of compound and package size its own SKU — a stable internal code that stays constant even if the display title changes, and that’s what actually links a specific variant to its inventory record and CoA. A product page’s variant selector (size, pack quantity) is choosing between different SKUs under one parent listing, not different products; that’s why the CoA or documentation linked from a listing needs to correspond to the exact variant selected, not just the product family. Catalogs also typically group listings into a small number of top-level categories — single peptides, blends, and lab consumables or accessories are a common three-way split — which is a useful first filter when you already know which structural type of product you’re looking for, before you start comparing individual listings within it.
What “research grade” means, and doesn’t
“Research grade” is a common catalog descriptor, and it is worth being precise about what the phrase actually asserts. In practice, it signals that a product is manufactured and sold for laboratory and in-vitro research use, not for human or animal consumption, and that it is not held to a pharmaceutical-grade manufacturing standard (such as cGMP production for a marketed drug product). It does not, by itself, specify a purity threshold, a testing method, or a sterility standard — those are separate, specific claims that belong on the CoA, not implied by the grade label. Two products both labeled “research grade” can have meaningfully different purity and testing documentation behind them; the label describes the product’s intended use category, not its analytical rigor.
Reading a strength table
A single-peptide listing that offers several milligram strengths typically presents them as a small table or a row of size buttons — for example 5 mg, 10 mg, and 15 mg options under one product title. Each row in that table is a distinct SKU, and in a well-built catalog each one is expected to carry (or link to) its own lot-specific CoA, since a higher milligram strength isn’t necessarily filled from the identical synthesis lot as a lower one. The table format itself is worth reading carefully: a size listed without a corresponding CoA link, next to sizes that do have one, is a gap worth asking about rather than assuming the missing documentation simply carries over from a neighboring size.
Naming inconsistencies across catalogs
Compound naming is not fully standardized across suppliers, and a catalog reader comparing listings across more than one source will run into real inconsistency: the same compound can appear under a common name, an abbreviated code, or a sequence-derived label depending on which catalog you’re reading, and two suppliers occasionally use the same short code for genuinely different compounds. This is exactly why a sequence identifier or CAS number — where a listing provides one — is worth cross-checking rather than assuming a familiar-looking name means the same molecule everywhere. When a name is unfamiliar or ambiguous, the CoA’s stated mass result is the most reliable way to confirm what a listing is actually describing, independent of what any given catalog chose to call it.
Reading a listing end to end
Put together, a well-structured catalog listing should let you answer, without leaving the page: what compound (or compounds, for a blend) is in the vial; what package size and pack quantity you’re ordering; and where to find the lot-specific testing documentation that backs the purity and identity claims for what you’re about to receive. If any of those three is unclear from the listing itself — the compound isn’t named specifically, the size and pack quantity are ambiguous, or there’s no path to a CoA — that ambiguity is worth resolving before ordering, not after.
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.